The present invention provides a novel antibody-pyrrolodiazepine derivative and a novel antibody-pyrrolodiazepine derivative conjugate using the same, and a novel CLDN6 and/or CLDN9 antibody.
Jhaumeer-Laulloo; Khodabocus; Jugoo, Journal of the Indian Chemical Society, 2003, vol. 80, # 8, p. 765 - 768